|
|
Article: Zenith Goldline Markets Balanced Generics Line.(Statistical Data Included)
- Article from:
- Chain Drug Review
- Article date:
- September 27, 1999
CopyrightCOPYRIGHT 1999 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
`Our clozapine program is a first'
MIAMI -- Zenith Goldline Pharmaceuticals Inc. develops, manufactures and markets generic medications to wholesalers, drug chains, other retail pharmacies, hospital groups, nursing home providers and government agencies in the United States.
Zenith Goldline is a subsidiary of Miami-based Ivax Corp., a holding company with subsidiaries engaged in the research, development, manufacture and marketing of branded and generic pharmaceuticals worldwide.
In 1998 Ivax reported net revenues of approximately $638 million and earnings per share from continuing operations of 21 cents. Through the first half of 1999, ended ...